Clinical trial
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
NCT03867916
Study timeline
Study start (actual)2018-12-13Date precision: day
Registry last updated2023-01-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Caregiverunresolved
Malignant Neoplasmunresolved
Physicianunresolved
Stage I Colorectal Cancer AJCC v8unresolved
Stage I Liver Cancerunresolved
Stage I Lung Cancer AJCC v8unresolved
Stage IA1 Lung Cancer AJCC v8unresolved
Stage IA2 Lung Cancer AJCC v8unresolved
Stage IA3 Lung Cancer AJCC v8unresolved
Stage IB Lung Cancer AJCC v8unresolved
Stage II Colorectal Cancer AJCC v8unresolved
Stage II Liver Cancerunresolved
Stage II Lung Cancer AJCC v8unresolved
Stage IIA Colorectal Cancer AJCC v8unresolved
Stage IIA Lung Cancer AJCC v8unresolved
Stage IIB Colorectal Cancer AJCC v8unresolved
Stage IIB Lung Cancer AJCC v8unresolved
Stage IIC Colorectal Cancer AJCC v8unresolved
Stage III Colorectal Cancer AJCC v8unresolved
Stage III Liver Cancerunresolved
Stage III Lung Cancer AJCC v8unresolved
Stage IIIA Colorectal Cancer AJCC v8unresolved
Stage IIIA Lung Cancer AJCC v8unresolved
Stage IIIB Colorectal Cancer AJCC v8unresolved
Stage IIIB Lung Cancer AJCC v8unresolved
Stage IIIC Colorectal Cancer AJCC v8unresolved
Stage IIIC Lung Cancer AJCC v8unresolved
Interventions
Sponsors & collaborators
University of California, San Franciscolead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03867916 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.